AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.

AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever ...

To create truly adaptable strategies, you have to hammer out the core problems and explore multiple solutions.

The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

The programme aims to address barriers for CROs, enabling them to reduce clinical trial timelines by at least 50%.

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in ...

Regarding AI in the dermatology community, ‘there’s fear, but there’s also enthusiasm — sometimes enthusiasm to the point of ...

During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...